Related Experiment Videos
More Answers and More Questions About Radiotherapy for Metastatic Prostate Cancer
Bridget F Koontz1, Thomas A Hope2
1Department of Radiation Oncology, Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina.
JAMA Oncology
|February 18, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical Imaging of 225Ac in a PET Scanner via Time-of-Flight Cascade γ-Ray Imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Pivotal Phase 3 Theranostic Trials: Future Indications.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
PSMA-PET Tumor Volume Stratifies Nonmetastatic Castration-resistant Prostate Cancer.
European urology focus·2026
Clinical Trial Protocol for LPS-Boost: Intensified [177Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Combined Maximum Tolerated Activity and Lesion-based Dosimetry for Personalized Radioiodine Therapy in Metastatic Differentiated Thyroid Carcinoma: An Early Institutional Experience.
Molecular imaging and radionuclide therapy·2026